Maintain Sustainable Lifestyle Changes
Continue individualized dietary improvement and physical activity rather than treating lifestyle change as a short-term intervention.
Fatty Liver Treatment in Pune
What Is Fatty Liver Disease?
Steatotic liver disease describes excess fat accumulation in the liver. The term MASLD — metabolic dysfunction-associated steatotic liver disease — is used for fatty liver associated with cardiometabolic risk factors such as overweight or obesity, diabetes, hypertension and abnormal cholesterol.
Simple Steatosis
Fat may accumulate in the liver without significant inflammation or advanced scarring, but assessment is important because disease severity varies between individuals.
MASH
Metabolic dysfunction-associated steatohepatitis (MASH) refers to fatty liver accompanied by liver inflammation and can progress to fibrosis.
Advanced Liver Disease
Progressive fibrosis can lead to cirrhosis and, in some patients, liver-related complications.
What Is Fatty Liver?
Fatty liver means excess fat has accumulated in the liver. The cause and amount of liver damage can vary, so a fatty-liver finding may need further assessment to understand fibrosis risk and overall liver health.
Book Consultation
Clinical pathway
What Causes Fatty Liver?
Fatty liver can occur in different clinical contexts. MASLD is associated with cardiometabolic risk factors, while alcohol intake, medicines and other possible causes also need to be reviewed so the treatment plan matches the underlying condition.
1
Overweight or Obesity
Excess body weight is a relevant metabolic risk factor in MASLD and should be assessed as part of the overall clinical picture.
2
Diabetes or Prediabetes
Diabetes and impaired glucose regulation are important metabolic factors to review when fatty liver is identified.
3
High Cholesterol & Blood Pressure
Abnormal cholesterol, high blood pressure and related metabolic risk factors should be considered during evaluation.
4
Alcohol, Medicines & Other Causes
Alcohol intake, medicines and other possible causes of steatosis should be reviewed so the correct condition is identified.
What Causes Fatty Liver?
Fatty liver can be associated with metabolic risk factors such as overweight or obesity, diabetes, high blood pressure and abnormal cholesterol. Alcohol intake, medicines and other possible causes also need to be reviewed.
Book ConsultationWhat Are the Symptoms of Fatty Liver?
Fatty liver may be identified on imaging or during investigation of abnormal liver tests, and it may cause few or no noticeable symptoms, especially earlier in the disease course. Symptoms are not a reliable measure of liver damage.
Few or No Noticeable Symptoms
Many people with fatty liver may have no specific symptoms, particularly earlier in the disease course
Abnormal Liver Tests
Some people are identified during evaluation of abnormal liver enzymes rather than because of a specific symptom.
Fatty Liver on Imaging
A scan may identify fatty liver even when a person does not have prominent symptoms.
Symptoms Do Not Determine Severity
Clinically important liver disease can exist without dramatic symptoms, so fibrosis and overall liver health need separate assessment.
Advanced Disease May Change the Picture
As liver disease progresses, complications can become more clinically apparent and require specialist evaluation.
Clinical Assessment Matters
Symptoms should be interpreted together with the underlying cause, liver tests, imaging and fibrosis risk rather than used as a standalone screening tool.
What Are the Symptoms of Fatty Liver?
Fatty liver may cause few or no noticeable symptoms, especially earlier in the disease course. Because symptoms are not a reliable measure of liver damage, abnormal liver tests or a fatty-liver finding on imaging should be assessed in context.
Book Consultation
Multidisciplinary care
What Are the Complications of Fatty Liver?
A subset of patients with steatotic liver disease progresses from fat accumulation to inflammation, fibrosis and cirrhosis. The risk of complications depends on disease stage and patient-specific factors.
MASH
Fat accumulation accompanied by liver inflammation can progress to fibrosis in some patients.
Liver Fibrosis
Progressive scarring can develop over time and is an important marker of disease severity.
Cirrhosis
Advanced fibrosis can lead to cirrhosis and loss of liver reserve, with complications requiring specialist management.
Liver Failure
Severe advanced liver disease can result in significant loss of liver function.
Liver Cancer Risk
Advanced steatotic liver disease and cirrhosis are associated with increased liver-related cancer risk; surveillance depends on stage and risk factors.
Portal Hypertension & Other Complications
Advanced cirrhosis can produce portal-hypertension-related complications and may require coordinated specialist care.
Can Fatty Liver Lead to Cirrhosis or Liver Cancer?
Yes. A subset of patients with progressive steatotic liver disease can develop fibrosis and eventually cirrhosis, and advanced liver disease is associated with increased liver-related cancer risk. Individual risk depends on the underlying condition and disease stage.
Book Consultation
Diagnosis
How Is Fatty Liver Diagnosed and Evaluated?
A fatty-liver finding on ultrasound or another scan does not by itself determine how much liver damage is present. Clinical assessment and non-invasive tests are used to estimate fibrosis risk and understand the overall liver condition.
Review Metabolic & Liver Risk Factors
Liver Blood Tests
Ultrasound & Imaging
Fibrosis Risk Assessment
FibroScan / Elastography
Additional Specialist Evaluation
How Is Fatty Liver Diagnosed?
Evaluation may include liver blood tests, ultrasound or other imaging, and non-invasive fibrosis assessment such as elastography. The exact testing pathway depends on the patient and the clinical question.
Book Consultation
Patient Journey
How Is Fatty Liver Treated?
Fatty liver treatment is individualized. Lifestyle and metabolic-risk management remain central, while selected patients with more advanced disease may require additional medical treatment and specialist follow-up.
Assess the Underlying Cause
Identify metabolic risk factors and review alcohol intake, medicines and other possible causes so treatment addresses the correct condition.
Weight
Management
For people with MASLD who are overweight or obese, sustained weight loss can improve liver fat, inflammation and fibrosis. The supplied source notes that a 5–10% reduction in body weight is associated with clinically meaningful liver improvements.
Dietary
Improvement
Sustainable dietary improvement, including patterns emphasizing vegetables, whole foods, fibre and unsaturated fats, can support metabolic health.
Physical
Activity
Regular physical activity is a core part of management and should be individualized to the person's health and clinical circumstances.
Manage Metabolic Conditions
Diabetes, high blood pressure, abnormal cholesterol and excess weight should be addressed as part of comprehensive care.
Medical Treatment & Specialist Follow-Up
Selected patients with more advanced disease may require additional medical treatment. Specific medicines or regimens should be determined from current clinical assessment and clinician-approved guidance.
How Is Fatty Liver Treated?
Fatty liver treatment focuses on addressing the underlying cause, improving metabolic health, supporting sustained weight management, diet and physical activity, and providing additional medical care when clinically indicated.
Book ConsultationCan Fatty Liver Be Reversed?
In many people, reducing metabolic risk and achieving sustained weight loss can improve liver fat and other features of MASLD. The extent of improvement depends on the stage of disease and whether fibrosis or MASH is present.
Book ConsultationWhat Happens After Fatty Liver Treatment?
Long-term management focuses on maintaining improvements in metabolic risk, monitoring liver health and identifying patients whose disease requires closer specialist follow-up.
Monitor Metabolic Risk Factors
Ongoing attention to weight, diabetes or prediabetes, blood pressure and cholesterol supports long-term liver and cardiovascular risk management.
Repeat Liver Assessment When Indicated
Follow-up blood tests, imaging or fibrosis assessment may be used according to the patient's clinical status.
Monitor Fibrosis and Cirrhosis Risk
Patients with fibrosis or established cirrhosis may need more structured specialist follow-up and surveillance appropriate to their stage.
How Is Fatty Liver Monitored After Treatment?
Follow-up depends on the patient's clinical status and may include monitoring metabolic risk, liver tests, imaging and fibrosis risk. Patients with established cirrhosis may require ongoing specialist follow-up and surveillance.
Book ConsultationWhat Happens When Fatty Liver Becomes Advanced?
Fatty liver can become clinically more complex when progressive inflammation and fibrosis have resulted in cirrhosis or other advanced liver disease. These patients may require coordinated hepatology, liver surgery, transplant and supportive care.
1
MASH & Progressive Fibrosis
MASH can progress to fibrosis in some patients, making fibrosis assessment important when fatty liver is identified.
→
2
Advanced or Decompensated Cirrhosis
Advanced disease can involve loss of liver reserve and complications that require specialist management.
→
3
Liver Cancer Risk
Advanced steatotic liver disease and cirrhosis are associated with increased liver-related cancer risk; surveillance depends on disease stage and risk factors.
→
4
Advanced Liver-Care Pathways
Care may involve complication management, closer monitoring, nutritional/supportive care, cancer surveillance when appropriate and assessment for advanced liver-care pathways.
→
What Are the Signs That Fatty Liver Has Caused Advanced Liver Disease?
Evidence of advanced fibrosis or cirrhosis, liver-related complications, worsening liver function or other signs of advanced disease can require specialist assessment.
Book ConsultationFatty Liver and Liver Transplant in Pune
Most people with fatty liver disease do not need a liver transplant. Transplant evaluation becomes relevant when MASLD has progressed to advanced or decompensated cirrhosis, liver failure or selected liver-cancer indications.
Advanced or Decompensated Liver Disease
Transplant evaluation may become relevant when advanced disease has significantly impaired liver function or complications are difficult to control.
Selected Liver Cancer Indications
Some patients with liver cancer arising in the setting of chronic liver disease may be evaluated for transplantation according to established criteria.
Assessment of Overall Health
The transplant team considers liver disease severity together with overall health and other relevant clinical factors.
Living- and Deceased-Donor Pathways
Where transplantation is appropriate, patients may be evaluated through applicable living-donor or deceased-donor pathways subject to medical, legal and allocation requirements.
Can Fatty Liver Require a Liver Transplant?
Most people with fatty liver do not need a transplant. Transplant evaluation is a pathway for selected patients whose disease has progressed to advanced liver disease or selected liver-cancer indications.
Book ConsultationWhen Is Liver Transplant Considered for Fatty Liver?
Liver transplantation is considered for selected patients whose fatty liver disease has resulted in advanced liver disease, liver failure or an established transplant indication. The decision is individualized and depends on liver function, complications, overall health and transplant eligibility.
Advanced Liver Failure
Significant loss of liver function may lead to transplant evaluation.
Decompensated Cirrhosis
Complications of advanced cirrhosis may indicate the need for specialist assessment for transplantation.
Liver Cancer in Selected Patients
Some patients with liver cancer may be evaluated for transplantation depending on tumour characteristics, liver function and established criteria.
Our Doctors
Meet Our Liver Transplant Surgeons & Hepatology Team
Dr. Manoj Shrivastav
MBBS · DNB (General Surgery) · Fellowship in Liver Transplantation, Global Hospital, Chennai
Dr. Manoj Shrivastav is a liver transplant surgeon at Ruby Hall Clinic, Pune, and currently leads the multi-organ transplant programme. He has personally completed over 200 liver transplants in Pune, 100 of them in the past year alone, with a survival rate above 95% and a one-year survival rate of 92% across his transplant series.
800+
Liver transplants
in Pune
in Pune
95%+
Survival
rate
rate
92%
One-year
survival rate
survival rate
He is equipped to handle acute surgical emergencies and trauma across a variety of scenarios, has performed major liver resections for hepatocellular carcinoma and cholangiocarcinoma, and believes a successful transplant depends on excellent teamwork across the entire clinical team — not one surgeon alone.
Meet the Team
FAQs
Frequently Asked Questions About Fatty Liver
Can fatty liver be reversed?
In many people, reducing metabolic risk and achieving sustained weight loss can improve liver fat and other features of MASLD. The extent of improvement depends on the stage of disease.
Is fatty liver the same as cirrhosis?
No. Fatty liver describes fat accumulation in the liver. Some patients progress to inflammation and fibrosis, and advanced fibrosis can eventually lead to cirrhosis.
Does everyone with fatty liver need medicine?
No. Treatment depends on the underlying cause and severity. Lifestyle and metabolic-risk management are central, while selected patients with more advanced disease may require additional medical treatment.
Can Cirrhosis Increase the Risk of Liver Cancer?
Yes. Cirrhosis is an important risk factor for hepatocellular carcinoma. Patients with cirrhosis may therefore require regular liver cancer surveillance as advised by their liver specialist.
Can fatty liver lead to liver cancer?
Advanced steatotic liver disease and cirrhosis can increase liver-related risks. Individual surveillance needs depend on the patient's stage and risk factors.
What tests are used for fatty liver?
Evaluation may include liver blood tests, ultrasound or other imaging, and non-invasive fibrosis assessment such as elastography. The exact pathway depends on the clinical situation.
What is MASLD?
MASLD means metabolic dysfunction-associated steatotic liver disease. It is the current term used for fatty liver associated with cardiometabolic risk factors such as overweight or obesity, diabetes, hypertension and abnormal cholesterol.
What is MASH?
MASH means metabolic dysfunction-associated steatohepatitis. It refers to fatty liver with inflammation and can progress to fibrosis.
When should I see a fatty liver specialist?
Specialist assessment is appropriate when liver tests remain abnormal, fibrosis is suspected, multiple metabolic risk factors are present, or cirrhosis or liver-related complications are identified.
Talk to the liver team
Get Your Fatty Liver Reports Reviewed by a Liver Specialist
Bring your liver blood-test reports, ultrasound or other scans, current medication list and relevant metabolic-health
information to your consultation.